Affimed (NASDAQ: AFMD) reported Q1 EPS of (EUR0.21), EUR0.02 worse than the analyst estimate of (EUR0.19). Revenue for the quarter came in at EUR4.51 million versus the consensus estimate of EUR5.63 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.